| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $-0.1B | $-0.1B | $-0.3B | $0.1B |
| EPS (Basic) | — | — | $-1.75 | $0.87 |
| EPS (Diluted) | — | — | $-1.75 | $0.87 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Total Assets | $6.3B | $6.2B | $6.6B | $11.8B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.7B | $0.9B | $0.4B |
| Total Liabilities | $5.8B | $5.4B | $5.7B | $10.2B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | — | — | — | — |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Operating Cash Flow | $-0.9B | $-0.2B | $4.5B | $-1.5B |
| Investing Cash Flow | $0.5B | $0.2B | $0.7B | $0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.1B |
| Financing Cash Flow | $0.2B | $-0.2B | $-4.8B | $1.3B |